Redefine
what's possible
See what’s next in managing your patients’ vision care needs with advanced VTI contact lens technology.
For those who’ve experienced it, you know NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses redefine vision for presbyopes and help you take control of paediatric myopia. With Neurofocus Optics® technology, these lenses offer crisp, clear vision at all distances1 and demonstrate a 96% decrease in the rate of myopia progression.2
Enhanced Multifocal for Myopia Progression Control - Asia
Featuring Patented Neurofocus Optics® Technology with an extended depth of focus (EDOF), centre distance design.1
Enhanced Multifocal for Presbyopia
NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses create an extended depth of focus to deliver a wider range of clear vision—unlike single vision or traditional multifocal lenses.1
Become a certified fitter
Focal Points
Visioneering Technologies, Inc. New Packaging Update
VTI will be introducing new brand packaging for NaturalVue® Enhanced Multifocal 1 Day Contact Lenses.
Astigmatism Press Release
New Data for Myopic Astigmatic Patients (GSLS)
PROTECT Press Release
Positive Interim 2-Year PROTECT (GSLS)
Celebrating Excellence in the UK Optical Industry
Celebrating Excellence in the UK Optical Industry
Defocus Press Release
VTI Releases Defocus Curve Data Evaluating the Functional Visual Range of the NaturalVue® Enhanced Multifocal EDOF Design for Presbyopia
PROTECT Press Release
VTI Continues Release of 1-Year Data from the Ongoing PROTECT Clinical Trial for Myopia Progression Control at the Global Specialty Lens Symposium
PROTECT Press Release
VTI Announces Positive Interim 1-Year Data from the PROTECT Clinical Trial for Myopia Progression Control at the American Academy of Optometry Annual Meeting
Aragón Named VTI CEO and Executive Director
Dr. Juan Carlos Aragón named as VTI’s Chief Executive Officer and Executive Director
MyPath Initiative Launched
VTI Launches the MyPath Myopia Education Initiative: The Path to Success in the Management of Myopia
6-Year Data Released
6-Year Myopia Progression Data for NaturalVue® Multifocal Announced at American Academy of Optometry’s Annual Meeting
New CMO Appointed
Visioneering Technologies, Inc. Appoints Ashley Tuan, OD, PhD as Chief Medical Officer
Visioneering Technologies Unveils New NaturalVue® Enhanced Multifocal™
The Enhanced Multifocal 1 Day™ Contact Lenses feature the TripleTear™ Lubrication System and a new Ultra-Tapered Edge
VTI/NaturalVue PFAS Statement
VTI has Confirmed with its Manufacturer that no NaturalVue Soft Contact Lenses are Formulated with Fluorinated Polymers or PFAS
7 New Markets Launched
Visioneering Technologies Launches New NaturalVue® Enhanced Multifocal™ in 7 Markets Simultaneously
6-Year Data Published
Visioneering Technologies Announces Publication of Peer-Reviewed Data from a 6-Year Myopia Progression Study in Clinical Ophthalmology
Enrollment Milestone
Visioneering Achieves 50% Enrollment Milestone in its PROTECT International Clinical Study for Myopia Progression Control
#GameOverMyopia
As video game use increases, the Global Myopia Awareness Coalition brings its message to gamers.
Global Expansion
VTI enters European sales and distribution agreement with Menicon, Japan’s largest contact lens company.
Educational Series
The first installment discusses treatment of children in clinical practice and features insights from world leading researchers and clinicians.
VTI UNVEILS NATURALVUE® SPHERE WITH COMFORT ENHANCERS
Clinical study shows new CleanComfort® technology provides more comfortable lens wear morning and night.
VTI LAUNCHES NATURALVUE® MULTIFOCAL CONTACT LENSES IN PLUS POWERS
Company now provides most expansive parameter range of any daily disposable multifocal.1
AWARD OF EXCELLENCE
Visioneering wins Award of Excellence for its NaturalVue® Multifocal 1 Day Contact Lenses at Australia’s largest eyecare event.
VTI SPONSORS
Visioneering Technologies, Inc., Sponsors “The Truth about Myopia – Part 2.”
VTI CONTINUES EXPANSION
Visioneering continues Asia expansion with registration achieved in Singapore.